Impact of Antirheumatic Treatments on the Individual Components of the American College of Rheumatology Composite Score in Patients With Rheumatic Arthritis: Real-World Data From 2 Registries

被引：0

作者：

Bessette, Louis ^{[1
]}

Movahedi, Mohammad ^{[2
]}

Choquette, Denis ^{[3
]}

Coupal, Louis ^{[3
]}

Bombardier, Claire ^{[4
]}

Keystone, Edward ^{[4
]}

机构：

[1] Laval Univ, Fac Med, Quebec City, PQ, Canada

[2] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada

[3] Inst Rhumatol Montreal, Montreal, PQ, Canada

[4] Univ Toronto, Toronto, ON, Canada

来源：

JOURNAL OF RHEUMATOLOGY | 2024年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：69 / 69

页数：1

共 36 条

[31] DOES BODY MASS INDEX IMPACT LONG-TERM RETENTION WITH ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE RECEIVED AT LEAST ONE PRIOR BIOLOGIC AGENT? 2-YEAR RESULTS FROM A REAL-WORLD, INTERNATIONAL, PROSPECTIVE STUDY
Nuesslein, Hubert
Alten, Rieke
Galeazzi, Mauro
Lorenz, Hanns-Martin
Nurmohamed, Michael T.
Bensen, William G.
Burmester, Gerd R.
Peter, Hans-Hartmut
Peichl, Peter
Pavelka, Karel
Chartier, Melanie
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
RHEUMATOLOGY, 2015, 54 : 186 - 187
[32] From Real-World Data to Improved Outcomes: Examining the Impact of Trastuzumab Disparities on Pathological Complete Response and Long-Term Survival in HER-2 Positive Breast Cancer Patients within the Brazilian Public Health System
Antonini, Marcelo
Mattar, Andre
Pannain, Gabriel
Richter, Fernanda Grace Bauk
Amorim, Andressa
Diogenes, Marina
Ferraro, Odair
Gebrim, Luiz
Lopes, Reginaldo Coelho
Real, Juliana
CANCER RESEARCH, 2024, 84 (09)
[33] The impact of TP53 mutations on EGFR mt plus NSCLC IV patients treated with 3rd generation TKI on 2nd line or further line therapy: Real-world data from two certified lung cancer centers in Germany
Roeper, J.
Christopoulos, P.
Falk, M.
Heukamp, L. C.
Stenzinger, A.
Thomas, M.
Griesinger, F.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S772 - S773
[34] COMET - effectiveness and tolerability of methocarbamol versus oral opioid-analgesics as add-on measure in patients with non-specific low back pain refractory to recommended 1st line treatments. A retrospective analysis of depersonalized propensity score matched open-label real-world 4-week data from the German Pain e-Registry
Ueberall, Michael A.
Mueller-Schwefe, Gerhard
CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (02) : 237 - 253
[35] Effectiveness of Teriparatide in the Treatment of Osteoporosis, Data from Real-World Clinical Practice George O. Tsoukas1, Alaa Dekis2, Philip H. Tsoukas3, Louise Ullyatt1, Fiona Vickers, George M. Tsoukas1 1 Division of Endocrinology, 2 Division of Rheumatology, McGill University Health Center; 3 Department of Medicine, University College Dublin.
Tsoukas, Georges
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S464 - S464
[36] COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan et al, 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al' by Andreica et al and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin et al
Gianfrancesco, Milena
Hyrich, Kimme L.
Yazdany, Jinoos
Machado, Pedro M.
Robinson, Philip C.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10)

← 1 2 3 4 →